GELFO, VALERIO
 Distribuzione geografica
Continente #
AS - Asia 1.736
NA - Nord America 1.526
EU - Europa 1.493
Continente sconosciuto - Info sul continente non disponibili 122
SA - Sud America 97
AF - Africa 91
OC - Oceania 3
Totale 5.068
Nazione #
US - Stati Uniti d'America 1.490
IT - Italia 706
SG - Singapore 488
CN - Cina 458
VN - Vietnam 392
DE - Germania 148
GB - Regno Unito 147
HK - Hong Kong 113
SE - Svezia 78
AT - Austria 77
BR - Brasile 76
FR - Francia 66
IE - Irlanda 66
IN - India 47
NL - Olanda 47
KR - Corea 41
RU - Federazione Russa 37
CI - Costa d'Avorio 36
JP - Giappone 32
FI - Finlandia 31
BD - Bangladesh 24
BG - Bulgaria 22
CA - Canada 22
ID - Indonesia 21
TG - Togo 21
JO - Giordania 19
TH - Thailandia 19
ZA - Sudafrica 18
PH - Filippine 16
AR - Argentina 13
CH - Svizzera 11
MY - Malesia 11
EE - Estonia 10
TW - Taiwan 9
IL - Israele 8
PL - Polonia 8
UA - Ucraina 8
ES - Italia 7
IQ - Iraq 7
MX - Messico 7
TR - Turchia 7
CZ - Repubblica Ceca 6
IR - Iran 6
PK - Pakistan 5
SA - Arabia Saudita 5
SC - Seychelles 5
EC - Ecuador 4
AU - Australia 3
DK - Danimarca 3
EG - Egitto 3
LT - Lituania 3
RO - Romania 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
BE - Belgio 2
CM - Camerun 2
CR - Costa Rica 2
HU - Ungheria 2
MA - Marocco 2
PY - Paraguay 2
UZ - Uzbekistan 2
AM - Armenia 1
BB - Barbados 1
DZ - Algeria 1
GR - Grecia 1
HN - Honduras 1
JM - Giamaica 1
LB - Libano 1
LV - Lettonia 1
LY - Libia 1
ML - Mali 1
MN - Mongolia 1
NP - Nepal 1
PE - Perù 1
PR - Porto Rico 1
SI - Slovenia 1
SV - El Salvador 1
TN - Tunisia 1
UY - Uruguay 1
Totale 4.946
Città #
Singapore 350
Bologna 333
Ashburn 210
Chandler 166
Hong Kong 101
Southend 101
Ho Chi Minh City 99
Hanoi 96
Hefei 93
San Jose 93
Santa Clara 77
Vienna 72
Dublin 63
Beijing 51
Boardman 51
Princeton 40
Seattle 40
Milan 39
Dallas 38
Redmond 38
Seoul 38
Abidjan 36
Fairfield 36
Los Angeles 28
Wilmington 28
Lauterbourg 27
Houston 26
Munich 25
Modena 22
Sofia 22
Amsterdam 21
Lomé 21
Tokyo 21
London 20
Amman 19
Helsinki 19
São Paulo 19
Woodbridge 19
Bremen 18
New York 18
Cambridge 16
Haiphong 16
Jakarta 16
Medford 16
Naples 16
Council Bluffs 15
Shanghai 15
Nanjing 14
Buffalo 13
Olalla 13
Berlin 12
Frankfurt am Main 12
Bangkok 11
Nuremberg 11
Orem 11
The Dalles 11
Westminster 11
Can Tho 10
Florence 10
Montreal 10
Saint Petersburg 10
Bern 9
Chicago 9
Da Nang 9
Manila 9
Redondo Beach 9
Ann Arbor 8
Jinan 8
Kuala Selangor 8
Rehovot 8
Rome 8
San Lazzaro di Savena 8
Shenyang 8
Turku 8
Basingstoke 7
Bengaluru 7
Boydton 7
Brooklyn 7
Cogollo del Cengio 7
Dearborn 7
Marcon 7
Reggio Emilia 7
Toronto 7
Xi'an 7
Düsseldorf 6
Forlì 6
Guangzhou 6
Jiaxing 6
Pelhrimov 6
Turin 6
Verona 6
Zhengzhou 6
Brescia 5
Ferrara 5
Padova 5
Phoenix 5
Prato 5
Stanford 5
Stockholm 5
Tân Tiến 5
Totale 3.170
Nome #
Extracellular Vesicles and Epidermal Growth Factor Receptor Activation: Interplay of Drivers in Cancer Progression 240
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 231
IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy 224
NF-kB oscillation profiles decode response to anti-EGFR monoclonal antibodies 223
Mechanisms of acquired resistance to cetuximab: role of interleukin-1 219
A Novel Role for the Interleukin-1 Receptor Axis in Resistance to Anti-EGFR Therapy 215
Aberrant MET activation impairs perinuclear actin cap organization with YAP1 cytosolic relocation 212
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in consensus molecular subtype 1 colon cancer 208
Roles of IL-1 in Cancer: From Tumor Progression to Resistance to Targeted Therapies 207
Senescence-associated reprogramming induced by interleukin-1 impairs response to EGFR neutralization 205
Modulation of ERBB signaling from tissue homeostasis to cancer progression 204
CEA Cell Adhesion Molecule 6 (CEACAM6), Collagen Type I Alpha 2 Chain (COL1A2), Galectin 4 (LGALS4) and Tetraspanin 8 (TSPAN8) mRNAs as blood biomarkers for colorectal cancer 197
Mechanisms of acquired resistance to cetuximab: role of interleukin 1 186
A putative role for interleukin 1 pathway in resistance to EGFR blockade 172
ERBB RECEPTORS DIMERIZATION DEFINES BREAST CANCERS SUBTYPES AND CLINICAL OUTCOMES: IMPLICATION FOR CANCER THERAPIES 166
Molecular mechanisms of resistance to cetuximab mediated by IL-1 signaling 163
The autocrine loop of ALK receptor and ALKAL2 ligand is an actionable target in Consensus Molecular Subtype 1 colon cancer 147
Decoding Ribosome Heterogeneity: A New Horizon in Cancer Therapy 147
A novel role for interleukin 1 axis in the resistance to EGFR targeting antibody 145
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 135
Senescence-associated reprogramming impairs response to EGFR neutralization 128
IL-1 Associated Post Senescence Reprogramming Impairs Response To EGFR Neutralization 124
null 121
null 117
A module of inflammatory cytokines defines resistance of colorectal cancer to EGFR inhibitors 113
Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies 104
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 98
Targeting anaplastic lymphoma kinase in consensus molecular subtype 1 colon cancer patients 95
MET receptor regulates perinuclear actin cap remodeling through YAP1 inactivation 94
Senescence-associated reprogramming impairs response to EGFR neutralization 84
IL-1 in the microenvironment impairs response to EGFR- neutralization in CRC patients 48
null 46
IL-1-mediated inflammation promotes metastatic dissemination and resistance to EGFR-targeted therapy 29
The therapeutic exploitation of IL-1 in cancer: Controlling tumor progression and resistance to targeted therapies 21
Totale 5.068
Categoria #
all - tutte 13.785
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.785


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022336 0 12 5 11 22 18 6 23 28 25 97 89
2022/2023739 58 76 39 97 62 59 24 78 126 16 44 60
2023/2024332 31 47 16 29 24 89 10 17 11 17 19 22
2024/20251.034 38 123 95 62 109 76 92 61 64 62 98 154
2025/20262.048 174 194 183 143 195 110 214 48 435 161 91 100
2026/202780 77 3 0 0 0 0 0 0 0 0 0 0
Totale 5.068